1911:TSEChina Renaissance Holdings Limited Analysis
Data as of 2026-05-20 - not real-time
HK$3.49
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
China Renaissance is trading at HK$3.49, which sits below its 20‑day SMA of 3.59 and far under the 200‑day SMA of 5.21, confirming a bearish price bias. The MACD line is negative and the signal line is higher, generating a bearish MACD signal, while the 14‑day RSI at 44 suggests limited upside momentum. The stock is hovering above the calculated support of 3.20 but below the resistance near 3.84, and the 30‑day volatility of 45.7% indicates a highly erratic price environment. Despite the technical weakness, the company posted a remarkable 55.8% revenue growth year‑over‑year and trades at a forward P/E of 2.66, far cheaper than the industry average P/E of 16.48. Its price‑to‑book ratio of 0.28 and an upside potential of over 260% versus the analyst target of HK$12.77 highlight a deep valuation gap. However, the balance sheet shows a high debt‑to‑equity ratio near 6 and modest profitability margins, which temper the enthusiasm. The firm carries no dividend, and cash flow generation appears weak, adding to the risk profile. Overall, the stock is technically bearish in the short run but fundamentally attractive for longer horizons, especially if the company can convert its revenue growth into sustainable earnings.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and modest RSI
- Proximity to near‑term support level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and low forward P/E
- Significant upside to analyst target price
- Improving market sentiment indicated by extreme greed index
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Deep valuation discount to book and earnings
- Potential to leverage cash reserves for strategic investments
- Long‑run secular growth of China’s new‑economy financing demand
Key Metrics & Analysis
Financial Health
Revenue Growth55.80%
Profit Margin8.15%
P/E Ratio15.9
ROE1.30%
ROA0.91%
Debt/Equity5.99
P/B Ratio0.3
Industry P/E16.5
Technical Analysis
TrendBearish
RSI43.9
SupportHK$3.20
ResistanceHK$3.84
MA 20HK$3.59
MA 50HK$3.60
MA 200HK$5.21
MACDBearish
VolumeIncreasing
Fear & Greed Index89.21
Valuation
Target PriceHK$12.77
Upside/Downside266.04%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.90
Volatility45.69%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.